Five important elements make up LEO Pharma’s unique innovation ecosystem:
- our internal R&D capabilities
- partnerships and acquisitions
- open innovation
- LEO Innovation Lab
- LEO Science & Tech Hub
Collaboration and co-creation is the glue that binds our ecosystem together, advancing science and technology to fuel the development of new treatment solutions.
LEO Pharma R&D
LEO Pharma’s R&D organisation is located at the company headquarters in Ballerup, Denmark, and consists of more than 700 scientists and specialists. Through internal innovation and external partnerships, the R&D organisation pioneers advances in dermatology care. Research and development projects are increasingly based on the efforts of multi-disciplinary project teams integrating advanced knowledge in R&D disciplines with expertise in clinical practice and therapeutic needs. Insight-driven innovation drives all product development.
LEO Pharma’s commitment to research and development is strengthened by extensive collaborations between the R&D organisation and more than 400 academic and institutional research centres and industry partners worldwide, making the world our lab. By collaborating with scientific experts globally, LEO Pharma aims to enhance its knowledge of skin diseases and explore new potential treatments.
LEO Pharma Open Innovation is a platform for exploring opportunities for drug discovery with external partners. It allows external partners to submit compounds for testing in the unique research tools at LEO Pharma’s laboratories. To ensure compound confidentiality, we do not ask for structures of confidential compounds. All the data generated by testing the partner's compounds is reported to the partner. Promising results can lead to a collaboration or business partnership.
LEO Innovation Lab
LEO Innovation Lab is LEO Pharma’s separate innovation unit, which develops non-pharmaceutical solutions in order to improve the lives of people with skin diseases. With satellites in Denmark, France, UK, US and Canada, LEO Innovation Lab develops apps, digital platforms and other initiatives to support people with skin diseases in areas such as diet and nutrition, health, fitness, dialogue with doctors and mental health. LEO Innovation Lab was established in 2015 for an initial period of three years with 60 Million EUR in funding. More than 50 people work at LEO Innovation Lab.
LEO Science & Tech Hub
The LEO Science & Tech Hub in Boston, United States, explores cutting-edge science and technology opportunities with relevance to dermatology. By partnering with public and private institutions in the world’s leading life science cluster in Boston, LEO Science & Tech Hub acts as a catalyst to transform early-stage innovations and technologies into solutions that will improve the quality of life for people with skin diseases. LEO Science & Tech Hub was officially inaugurated in September 2016.